Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study.
Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study. — المؤلف: Yimer, Habte — British journal of haematology 20200504
- المؤلف
- Yimer, Habte
- النشر
- British journal of haematology 20200504
- الوصف
- 492-502 p.
- الموضوعات
- Adult؛ Aged؛ Aged, 80 and over؛ Antibodies, Monoclonal؛ Antineoplastic Combined Chemotherapy Protocols؛ Autografts؛ Bortezomib؛ Cyclophosphamide